TICSX
Price
$7.04
Change
+$0.09 (+1.29%)
Updated
Jan 14 closing price
Net Assets
1.17B
VSCIX
Price
$116.18
Change
+$1.31 (+1.14%)
Updated
Jan 14 closing price
Net Assets
155.27B
Ad is loading...

TICSX vs VSCIX

Header iconTICSX vs VSCIX Comparison
Open Charts TICSX vs VSCIXBanner chart's image
Touchstone Small Company Instl
Price$7.04
Change+$0.09 (+1.29%)
VolumeN/A
Net Assets1.17B
Vanguard Small Cap Index I
Price$116.18
Change+$1.31 (+1.14%)
VolumeN/A
Net Assets155.27B
TICSX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TICSX vs. VSCIX commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TICSX is a Buy and VSCIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 155B vs. TICSX (1.17B). VSCIX pays higher dividends than TICSX: VSCIX (1.43) vs TICSX (0.00). TICSX was incepted earlier than VSCIX: TICSX (7 years) vs VSCIX (28 years). TICSX is a more actively managed with annual turnover of: 94.00 vs. VSCIX (12.00). TICSX has a lower initial minimum investment than VSCIX: TICSX (500000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 17.26 vs. TICSX (11.90). VSCIX return over 5 years is better than : 45.10 vs. TICSX (29.76).
TICSXVSCIXTICSX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years28 years-
Gain YTD1.0040.894112%
Front LoadN/AN/A-
Min. Initial Investment500000500000010%
Min. Initial Investment IRAN/AN/A-
Net Assets1.17B155B1%
Annual Yield % from dividends0.001.43-
Returns for 1 year11.9017.2669%
Returns for 3 years8.3011.5972%
Returns for 5 years29.7645.1066%
Returns for 10 yearsN/A120.65-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVAL2.210.05
+2.55%
Grupo Aval Acciones Y Valores SA
ALZN1.13-0.02
-1.74%
Alzamend Neuro Inc.
ZOM0.13N/A
-1.93%
Zomedica Corp
FLGT17.13-0.81
-4.52%
Fulgent Genetics
SMMT16.65-1.52
-8.39%
Summit Therapeutics